SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-001745
Filing Date
2020-01-23
Accepted
2020-01-23 13:11:40
Documents
3
Period of Report
2020-01-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20200123.htm 8-K 32291
2 EX-99.1 eypt-ex991_7.htm EX-99.1 27324
3 GRAPHIC gnhjk01dghfp000001.jpg GRAPHIC 4916
  Complete submission text file 0001564590-20-001745.txt   67872
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 20541339
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences